Glucagon-like peptide-1 analogs

Details Glucagon-like peptide-1 analogs Glucagon-like peptide-1 analogs

2006-09-05

2006-09-05

Gupta, Anish (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S012200, C530S308000, C530S324000

Reexamination Certificate

active

07101843

ABSTRACT:
Disclosed are glucagon-like peptide-1 (GLP-1) compounds with modifications at one or more of the following positions: 7, 8, 12, 16, 18, 19, 20, 22, 25, 27, 30, 33, and 37. Methods of treating a subject in need of GLP-1 receptor stimulation using these GLP-1 compounds are also disclosed.

REFERENCES:
patent: 5545618 (1996-08-01), Buckley et al.
patent: 0926159 (1999-06-01), None
patent: WO 91/11457 (1991-08-01), None
patent: WO 98/19698 (1998-05-01), None
patent: WO 99/30731 (1999-06-01), None
patent: WO 99/43341 (1999-09-01), None
patent: WO 99/43706 (1999-09-01), None
patent: WO 00/07617 (2000-02-01), None
patent: WO 00/55119 (2000-09-01), None
patent: WO 01/98331 (2001-12-01), None

Affiliated with

Also associated with

Rating

Glucagon-like peptide-1 analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Glucagon-like peptide-1 analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glucagon-like peptide-1 analogs will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3567285